Altered Glucagon Response to Oral Glucose in Individuals at Different Stages of Type 1 Diabetes Development
These findings highlight the need for prospective studies to further elucidate the role of alpha-cells in disease progression and support testing pharmacotherapies aimed at improving both alpha- and beta-cell functions during disease development.
Authors
- Riitta Veijola (ORCID: https://orcid.org/0000-0002-6557-270X)
- Jaakko J. Koskenniemi (ORCID: https://orcid.org/0000-0002-9348-3325)
- Jukka Kero (ORCID: https://orcid.org/0000-0001-8767-7222)
- Jorma Toppari (ORCID: https://orcid.org/0000-0003-2228-334X)
- Eliisa Löyttyniemi (ORCID: https://orcid.org/0000-0002-7278-6511)
- Luís Crisóstomo (ORCID: https://orcid.org/0000-0002-9563-6364)
- Helena Kontola (ORCID: https://orcid.org/0000-0002-0781-6286)
Institutions
- University of Turku (FI)
- University of South Florida (US)
- Oulu University Hospital (FI)
- Turku University Hospital (FI)
- Turku Centre for Biotechnology (FI)
- University of Oulu (FI)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2025-10-29
- DOI
- https://doi.org/10.1210/clinem/dgaf601
- Citations
- 1
- Primary Topic
- Pancreatic function and diabetes
- Type
- article
- Field-Weighted Citation Impact
- 2.01